Veterinary Medicines Information website

Clamaden 400 mg/100 mg chewable tablets for dogs

Authorised
  • Potassium clavulanate
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Clamaden 400 mg/100 mg chewable tablets for dogs
Active substance:
  • Potassium clavulanate
  • Amoxicillin trihydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Potassium clavulanate
    119.13
    milligram(s)
    /
    1.00
    Tablet
  • Amoxicillin trihydrate
    459.22
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Chewable tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Available in:
  • Latvia
Package description:
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 6 tablets. Carton contains 300 tablets
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 6 tablets. Carton contains 60 tablets
  • Blister formed of an aluminium foil which consists of aluminum layer coated with OPA (Oriented Polyamide) film on one side and PE with desiccant on the other side and an aluminium sealing foil which consists of aluminium layer and PE coating.Blister contains 6 tablets. Carton contains 12 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • KRKA tovarna zdravil d.d. Novo mesto
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/22/0008
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0652/003
Concerned member states:
  • Belgium
  • Croatia
  • Czechia
  • Estonia
  • France
  • Germany
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 13/10/2024
Updated on: 13/03/2026
Download

Combined File of all Documents

English (PDF)
Published on: 20/09/2026
Download
Latvian (PDF)
Published on: 12/10/2026
Download